Search results
Results from the WOW.Com Content Network
Over the past 5 years, ISR has been increasingly treated with a drug-coated balloon (DCB), which is a balloon coated with the same anti-cancer drugs that prevent restenosis, such as Paclitaxel. [ 15 ] [ 16 ] The balloon avoids the need for a double layer of metal which is used when an in-stent restenosis is treated with another stent within the ...
Staging breast cancer is the initial step to help physicians determine the most appropriate course of treatment. As of 2016, guidelines incorporated biologic factors, such as tumor grade, cellular proliferation rate, estrogen and progesterone receptor expression, human epidermal growth factor 2 (HER2) expression, and gene expression profiling into the staging system.
Kate Middleton is opening up about the long-term side effects of her cancer treatment.. On Tuesday, Jan. 14, the Princess of Wales spoke with staff during a surprise visit to the Royal Marsden ...
A drug-eluting stent (DES) is a small mesh tube that is placed in the arteries to keep them open in the treatment of vascular disease.The stent slowly releases a drug to block cell proliferation (a biological process of cell growth and division), thus preventing the arterial narrowing that can occur after stent implantation.
In September 2001, NICE recommended paclitaxel for the treatment of advanced breast cancer after the failure of anthracyclic chemotherapy, but that its first-line use should be limited to clinical trials. In September 2006, NICE recommended paclitaxel should not be used in the adjuvant treatment of early node-positive breast cancer. [18]
Amy Robach is long overdue for blood work. More than a year overdue, to be a bit more precise, and Robach admits it's "illogical and dumb" to continue to put it off, especially as a breast cancer ...
Body sites in which brachytherapy can be used to treat cancer. Brachytherapy is commonly used to treat cancers of the cervix, prostate, breast, and skin. [1]Brachytherapy can also be used in the treatment of tumours of the brain, eye, head and neck region (lip, floor of mouth, tongue, nasopharynx and oropharynx), [10] respiratory tract (trachea and bronchi), digestive tract (oesophagus, gall ...
Some patients may experience cognitive dysfunction up to 10 years after undergoing chemotherapy treatment. [2] PCCI is often seen in patients treated for breast cancer, ovarian cancer, prostate cancer, and other reproductive cancers, [4] as well as other types of cancers requiring aggressive treatment with chemotherapy. [5] [6]